CITI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 6.109
AS - Asia 3.466
EU - Europa 2.960
SA - Sud America 512
AF - Africa 166
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 4
Totale 13.227
Nazione #
US - Stati Uniti d'America 5.927
IT - Italia 1.388
SG - Singapore 1.067
CN - Cina 950
HK - Hong Kong 547
BR - Brasile 412
VN - Vietnam 411
SE - Svezia 373
DE - Germania 283
BG - Bulgaria 165
FR - Francia 157
GB - Regno Unito 130
CA - Canada 111
FI - Finlandia 102
IN - India 83
AT - Austria 81
JP - Giappone 74
RU - Federazione Russa 72
KR - Corea 68
TR - Turchia 66
CI - Costa d'Avorio 56
PL - Polonia 48
NL - Olanda 44
MX - Messico 39
BD - Bangladesh 38
AR - Argentina 36
ZA - Sudafrica 32
IQ - Iraq 30
CH - Svizzera 22
SA - Arabia Saudita 20
BE - Belgio 17
EC - Ecuador 17
KE - Kenya 16
SN - Senegal 15
UZ - Uzbekistan 14
ID - Indonesia 13
CO - Colombia 12
UA - Ucraina 12
VE - Venezuela 12
ES - Italia 11
GR - Grecia 11
NG - Nigeria 10
PK - Pakistan 10
EU - Europa 9
TN - Tunisia 9
CZ - Repubblica Ceca 7
EG - Egitto 7
MA - Marocco 7
DK - Danimarca 6
DZ - Algeria 6
HU - Ungheria 6
IL - Israele 6
JM - Giamaica 6
JO - Giordania 6
PS - Palestinian Territory 6
TW - Taiwan 6
BO - Bolivia 5
LT - Lituania 5
MY - Malesia 5
NI - Nicaragua 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CL - Cile 4
NP - Nepal 4
RO - Romania 4
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GT - Guatemala 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
LV - Lettonia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
GD - Grenada 1
GY - Guiana 1
Totale 13.212
Città #
Ashburn 634
Singapore 584
Hong Kong 532
San Jose 474
Fairfield 457
Serra 384
Santa Clara 358
Woodbridge 352
Dallas 348
Chandler 310
Houston 258
Seattle 208
Ann Arbor 197
Beijing 197
Wilmington 167
Sofia 164
Shanghai 162
Milan 146
Cambridge 129
New York 123
Boardman 121
Council Bluffs 119
Los Angeles 119
Chicago 111
Hefei 99
Hanoi 89
Ho Chi Minh City 86
Pisa 83
Munich 79
Princeton 79
Vienna 73
Lawrence 66
Florence 64
Tokyo 63
Rome 62
Seoul 62
Lauterbourg 60
Ottawa 59
Frankfurt am Main 58
London 57
Medford 57
Abidjan 56
Helsinki 43
Dong Ket 42
Warsaw 42
Buffalo 38
Des Moines 38
São Paulo 38
Istanbul 30
Nanjing 30
Redondo Beach 28
Orem 26
Salt Lake City 26
Turku 24
Lucca 22
Marseille 22
Johannesburg 21
Dearborn 20
Da Nang 19
Livorno 19
Naples 18
Nuremberg 18
San Diego 18
Zurich 18
Boulder 17
Grafing 17
Phoenix 17
Elk Grove Village 16
Izmir 16
Lappeenranta 16
Dakar 15
Paris 15
Atlanta 14
Brussels 14
Quanzhou 14
Amsterdam 13
Bremen 13
Fuzhou 13
Mumbai 13
Redwood City 13
The Dalles 13
Toronto 13
Baltimore 12
Brooklyn 12
Guangzhou 12
Mexico City 12
San Francisco 12
Tianjin 12
Washington 12
Düsseldorf 11
Montreal 11
Nanchang 11
Napoli 11
Ogden 11
Tashkent 11
Baghdad 10
Haiphong 10
Massa 10
Tampa 10
Belo Horizonte 9
Totale 8.967
Nome #
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 308
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 299
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 259
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 249
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 238
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 235
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 226
Metformin conjugates and therapeutic use thereof 226
Memantine prodrug as a new agent for alzheimer’s disease 226
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 224
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 222
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 217
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 214
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 209
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 205
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 204
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 199
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 198
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 194
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 188
Association of Myo-Inositol and Microlipodispersed Magnesium in Androgen-Dependent Dermatological Diseases: A Retrospective Study 186
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 180
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 178
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 178
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 177
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 173
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 172
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 171
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 170
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 163
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 153
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 153
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 151
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 151
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 150
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 148
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 148
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 147
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 144
A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions 143
null 142
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 140
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 135
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 133
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 133
Nutraceutical Features of the Phycobiliprotein C-Phycocyanin: Evidence from Arthrospira platensis (Spirulina) 131
Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches 131
Cardiovascular benefits of Eruca sativa mill. Defatted seed meal extract: Potential role of hydrogen sulfide 130
Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity 129
Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying in vivo cardioprotective activities 128
Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug 127
Organic Isothiocyanates as Hydrogen Sulfide Donors 125
Vascular effects of H2S-donors: Fluorimetric detection of H2S generation and ion channel activation in human aortic smooth muscle cells 124
Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications 124
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 123
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 122
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma 122
Searching for novel hydrogen sulfide donors: The vascular effects of two thiourea derivatives 122
Role of hydrogen sulfide in cardiovascular ageing 117
In Vitro Models of Diabetes: Focus on Diabetic Retinopathy 116
Plants and Mushrooms as Possible New Sources of H2S Releasing Sulfur Compounds 114
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors 113
null 113
New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways 106
Functional recovery of islet β cells in human type 2 diabetes: Transcriptome signatures unveil therapeutic approaches 101
Pharmacological evaluation of aryl-isothiocyanates as original H2S-donor derivatives: H2S-release and vascular effects 101
Natural organo-sulfur compounds inhibit RBL-2H3 mast cell degranulation 100
null 100
The novel H2S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium 99
Hybrids between H2S-donors and betamethasone 17-valerate or triamcinolone acetonide inhibit mast cell degranulation and promote hyperpolarization of bronchial smooth muscle cells 99
null 98
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 97
The h2 s-donor erucin exhibits protective effects against vascular inflammation in human endothelial and smooth muscle cells 95
Influence of Polyphenols on Adipose Tissue: Sirtuins as Pivotal Players in the Browning Process 94
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 94
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer. 93
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse 93
null 92
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial 92
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID-19 therapy 92
Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing 90
Using hydrogen sulfide to design and develop drugs 87
Isothiocyanate-Corticosteroid Conjugates against asthma: Unity makes strength 85
Should CYP2D6 be genotyped when treating with tamoxifen? 78
Hydrogen sulfide: The hidden player of isothiocyanates pharmacology 76
Recent Advancements in Production and Extraction Methods of Phycobiliprotein C-phycocyanin by Arthrospira (Spirulina) platensis: A Mini Review 74
Synthesis and biological evaluation of N–O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection 71
Pharmacological evaluation of innovative eye drop formulations containing TS-polysaccaride, hyaluronic acid and glycyrrhizin for irritative ocular diseases using in vitro reconstituted human corneal epithelium model 69
Regulation of blood pressure by natural sulfur compounds: Focus on their mechanisms of action 66
Potential Effects of Natural H2 S-Donors in Hypertension Management 64
null 60
Glucoraphanin Increases Intracellular Hydrogen Sulfide (H2S) Levels and Stimulates Osteogenic Differentiation in Human Mesenchymal Stromal Cell 59
Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis 59
Design, synthesis and biological evaluation of new H2S-releasing rivastigmine derivatives as neuroprotective molecules 58
Real-World Pilot Evaluation of a Novel Bioavailable Berberine Formulation (ToBeRock®) in Subjects with Impaired Fasting Glucose Through Pharmacy-Based Retrospective Study 53
Glucotropaeolin-enriched Lepidium sativum L. extract as a novel phytotherapy for tendinopathy: mechanistic insights into pain modulation 49
null 48
Naturally Occurring H2S-Donors in Vascular Diseases 36
Semi-Synthetic H2S Releasing Compounds with Antioxidant and Vasorelaxant Properties 32
Protective Effects on Keratinocytes by Extracts Enriched in Polysaccharides from Limnospira platensis Grown Under Autotrophic and Mixotrophic Conditions 24
Totale 13.554
Categoria #
all - tutte 38.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022771 23 24 17 22 126 135 25 34 47 39 67 212
2022/20231.272 149 179 98 80 125 162 12 80 245 15 74 53
2023/2024762 55 79 87 37 99 131 55 28 7 22 46 116
2024/20253.038 46 94 32 149 241 326 231 140 264 445 475 595
2025/20264.179 207 474 409 383 365 324 688 199 330 433 176 191
2026/202757 57 0 0 0 0 0 0 0 0 0 0 0
Totale 13.640